Interpreting the Complex Landscape of Immune-Tumor Interface.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 34389608.
- Also identified by DOI 10.1158/1078-0432.CCR-21-2208.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Predictive biomarkers for immune therapy must address a complex interface between the immune system and triple-negative breast cancer and still be technically reliable for diagnostic use. Two recent articles describe the assessment of spatial heterogeneity using digital methods that promise to improve the quantification of immune infiltrate or molecular targets.<i>See related articles by Bai et al., p. 5557 and Carter et al., p. 5628</i>.
Medical subject headings
- Triple Negative Breast Neoplasms